Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women
A completed pilot trial evaluating prophylactic management of lamotrigine in pregnant women with bipolar disorder, major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The Efficacy of Neural Stimulation in Individuals With Schizophrenia [NA]
This update reports the completed results of a neural stimulation intervention in individuals with schizophrenia. Results were posted on 202…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Relationship Between Physical Fitness and Psychopathology, Cognition and Quality of Life in Patients Diagnosed With Schizophrenia: a Mixed Method Study.
This ClinicalTrials.gov entry describes a mixed-method study examining how physical fitness relates to psychopathology, cognition, and quali…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis [NA]
Clinical trial update for the OPUS YOUNG study comparing early intervention versus treatment as usual for adolescents with first-episode psy…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Cognitive Training for Emotion Regulation in Psychotic Disorders [NA]
This clinical trial status update shows recruitment ongoing for a cognitive training program intended to improve emotion regulation in psych…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Minnesota Community-Based Cognitive Training in Early Psychosis [NA]
Update on the completed clinical trial of Minnesota's community-based cognitive training for people with early psychosis; results have been …
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole (ARIPIPRAZOLE) under ANDA216351.
-
FDA label_change · 2025-01-22FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics USA, Inc., resulting in an update to the …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Building Employment Skills Through Therapy for Veterans [NA]
This clinical trial update reports the completion of a VA-supported study evaluating therapy to build employment skills for veterans with sc…
-
FDA approval · 2025-01-22FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for CLOZAPINE from Mylan Pharmaceuticals Inc. The action relates to a modification of the generi…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Lifestyle Intervention for Young Adults With Serious Mental Illness [NA]
Completed results posted for a lifestyle intervention trial in young adults with serious mental illness, including schizophrenia, schizoaffe…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Shared Decision Making Training for Inpatients With Schizophrenia [NA]
This completed clinical trial evaluated a shared decision-making training program for inpatients with schizophrenia (and schizoaffective dis…
-
CLINICAL_TRIALS research · 2025-01-02Clinical Trial Update: Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode [NA]
This clinical trial update reports recruitment status for a study evaluating telehealth aerobic exercise plus cognitive training to improve …
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Motivation Skills Training for Schizophrenia [NA]
Completed clinical trial evaluating Motivation Skills Training for schizophrenia and schizoaffective disorder; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Randomized Double Blind Placebo Control Study in Patients with Schizophrenia [Phase 2]
Phase 2 randomized double-blind placebo-controlled trial in schizophrenia and related psychotic disorders has completed; sponsor: Pakistan I…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness [NA]
Clinical trial on a context-aware mobile intervention for social recovery in serious mental illness has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine [NA]
This ClinicalTrials.gov update shows a completed study on melatonin metabolism abnormalities in patients with schizophrenia or schizoaffecti…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement [Phase 2]
Phase 2 clinical trial update for rituximab in people with psychosis and obsessive-compulsive disorder with suspected immune involvement; re…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Service User and Staff Views on Digital Remote Monitoring for Psychosis
A completed clinical trial update reporting on the views of service users and staff regarding digital remote monitoring for psychosis.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: M1 Schizophrenia PET Study [Phase 1]
A Phase 1 PET imaging study (M1) at Yale University investigating schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia [NA]
This update reports a completed clinical trial evaluating a mobile-assisted cognitive behavioral therapy intervention for negative symptoms …
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile CBT for Negative Symptoms [NA]
A completed clinical trial evaluating mobile cognitive-behavioral therapy for negative symptoms in schizophrenia and schizoaffective disorde…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment [Phase 4]
Phase 4 trial comparing remimazolam and etomidate as induction agents for electroconvulsive therapy has completed, potentially informing ane…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 [Phase 3]
Phase 3 study evaluating pharmacokinetics and safety/tolerability of Long-Acting Oral LYN-005 in schizophrenia and schizoaffective disorder …
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia [NA]
The NST-SPARK trial reports completion of a preliminary study evaluating an augmented reality app delivering recovery-oriented cognitive the…